<\/p>\n
Ondem MD<\/strong> \u00e4r en orally disintegrating tablet (ODT\/MD)<\/strong> av ondansetron 4 mg \/ 8 mg<\/strong>, a selective serotonin 5-HT3 receptor antagonist<\/strong>. It is the most-used antiemetic worldwide and works against the strong serotonergic emetic stimulus generated by chemotherapy, radiation, surgery, gastroenteritis, and migraine. Manufactured by Alkem under WHO-GMP standards. Onset within 30 minutes orally and 8–12 hour duration; usually given 30–60 minutes before chemo or as needed for breakthrough nausea.<\/p>\n<\/div>\n \ud83d\udce6 Varje best\u00e4llning omfattas av v\u00e5r Reshipment Assurance Policy<\/strong><\/a> \u2014 om din f\u00f6rs\u00e4ndelse inte anl\u00e4nder inom 20 arbetsdagar, skickar vi om den.<\/p>\n V\u00e5ra generiska l\u00e4kemedel kommer fr\u00e5n WHO-GMP-certifierade tillverkare och skickas v\u00e4rldsvidt i diskreta, enkla f\u00f6rpackningar \u2014 inget l\u00e4kemedelsnamn p\u00e5 f\u00f6rs\u00e4ndelsens utsida. Kortbetalningar hanteras via en reglerad betalningsprocessor (kontoutdrag visar en reglerad kortbetalningsprocessor \u2014 aldrig \u201cMedsBase\u201d eller n\u00e5got l\u00e4kemedelsnamn). Krypto och SEPA-bank\u00f6verf\u00f6ring accepteras ocks\u00e5. Varje best\u00e4llning backas upp av v\u00e5r Reshipment Assurance Policy.<\/p>\n Ondansetron is the first-line antiemetic for serotonin-driven nausea<\/strong> — chemotherapy-induced nausea and vomiting (CINV), post-operative nausea and vomiting (PONV), radiation-induced nausea, and severe gastroenteritis. It is less useful for motion sickness and vestibular nausea<\/strong> (where the dominant pathway is histaminergic and cholinergic — promethazine\/Avomine, cinnarizine, and meclozine work better) and not first-line for nausea-vomiting of pregnancy<\/strong> (NVP first-line is doxylamine + B6; ondansetron is reserved for refractory hyperemesis gravidarum after considering a small first-trimester cardiac\/cleft-palate signal in observational studies).<\/p>\n Ondem MD is supplied from a WHO-GMP-certifierad tillverkare<\/strong>. Varje best\u00e4llning skickas diskret \u00f6ver hela v\u00e4rlden och omfattas av v\u00e5r Reshipment Assurance Policy<\/a> — if it does not arrive within 20 business days, we reship at no cost. Ondansetron is the global standard for serotonin-driven emesis with millions of doses delivered safely each year. Orally disintegrating tablet (ODT\/MD) formulation is convenient when active vomiting prevents reliable swallowing.<\/p>\n Chemotherapy, radiation, and surgery damage gut enterochromaffin cells, which release massive amounts of serotonin (5-HT)<\/strong>. The serotonin binds 5-HT3 receptors on vagal afferents and on the chemoreceptor trigger zone (area postrema), which signal the medullary vomiting centre. Ondansetron is a highly selective antagonist at the 5-HT3 receptor — it blocks this signal at both peripheral and central sites without affecting D2, H1, muscarinic, or alpha-adrenergic receptors. That selectivity explains its clean side-effect profile: minimal sedation, no extrapyramidal reactions, no anticholinergic burden.<\/p>\nVarf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n
When ondansetron is the right antiemetic<\/h2>\n
Varf\u00f6r best\u00e4lla fr\u00e5n MedsBase<\/h3>\n
Verkningsmekanism<\/h2>\n
Indikationer<\/h2>\n
\n
Dos<\/h2>\n